Apr 02, 2014
5:4
For every 4 shares held, investors received 5. The price per share adjusted from $14.75 to $11.80.
The split itself did not change the total investment value.
Astellas Pharma Inc. (ALPMY) trades on the Other OTC in the Drug Manufacturers - General industry.
Astellas Pharma Inc. company overviewThe latest split shown was on April 2, 2014. It was a 5-for-4 forward split, so shareholders received 5 shares for every 4 they held.
This history records 2 forward splits between May 13, 2013 and April 2, 2014.
Already premium? Sign in